CyberKnife frameless Image-Guided high-dose fractionated stereotactic radiosurgery with the synchrony motion tracking module in the treatment of single small peripheral lung tumors

Brian T. Collins, Kelly Erickson, Sean P. Collins, Gregory J. Gagnon, Sonja Dieterich, Donald A. McRae, Cristina Reichner, Thomas Chang, Carlos Jamis-Dow, Filip Banovac, Shakun Malik, Eric D. Anderson

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Curative surgery is not an option for many patients with clinical stage I non-small-cell lung carcinoma (NSCLC) because of associated comorbidities. Stereotactic radiosurgery with the CyberKnife® (Accuray Incorporated, Sunnyvale, CA) tumor tracking system may be an option for many of these medically inoperable patients. Here we provide a concise overview of the standard treatment options for stage I lung cancer and a practical summary of the Georgetown University Hospital stereotactic radiosurgery treatment protocol. We review preliminary outcomes for single small peripheral lung tumors uniformly treated with the CyberKnife using the Synchrony® (Accuray Incorporated, Sunnyvale, CA) motion tracking module.

Original languageEnglish (US)
Title of host publicationTreating Tumors that Move with Respiration
PublisherSpringer Berlin Heidelberg
Pages145-153
Number of pages9
ISBN (Print)9783540698852
DOIs
StatePublished - 2007

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'CyberKnife frameless Image-Guided high-dose fractionated stereotactic radiosurgery with the synchrony motion tracking module in the treatment of single small peripheral lung tumors'. Together they form a unique fingerprint.

Cite this